Horizon Therapeutics PLC
NASDAQ:HZNP

Watchlist Manager
Horizon Therapeutics PLC Logo
Horizon Therapeutics PLC
NASDAQ:HZNP
Watchlist
Price: 116.3 USD Market Closed
Updated: May 18, 2024

Revenue Breakdown

Breakdown by Geography
Horizon Therapeutics PLC

Total Revenue: 3.6B USD
100%
United States: 3.6B USD
98.9%
Non-Us: 39.5m USD
1.1%

Breakdown by Segments
Horizon Therapeutics PLC

Total Revenue: 3.6B USD
100%
Tepezza: 2B USD
54.2%
Krystexxa: 716.2m USD
19.7%
Ravicti: 325.7m USD
9%
Procysbi Developed Technology: 210m USD
5.8%
Uplizna: 154.6m USD
4.3%
Actimmune: 126.1m USD
3.5%
Pennsaid 2%: 73.8m USD
2%
Rayos: 41.9m USD
1.2%
Buphenyl: 7.3m USD
0.2%
Duexis: 4.9m USD
0.1%
Vimovo: 1.9m USD
0.1%
Quinsair: 1.1m USD
0%
Show More
Show Less

See Also

Discover More